Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hejtmancik, J. F.
Right arrow Articles by Caskey, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hejtmancik, J. F.
Right arrow Articles by Caskey, C. T.
NEUROLOGY 1986;36:1553
© 1986 American Academy of Neurology

Carrier diagnosis of Duchenne muscular dystrophy using restriction fragment length polymorphisms

J. F. Hejtmancik, S. G. Harris, C. C. Tsao, P. A. Ward and C. T. Caskey

Institute for Molecular Genetics (Drs. Hejtmancik, Harris, Tsao, Ward, and Caskey) and the Department of Medicine (Drs. Hejtmancik and Caskey), Baylor College of Medicine, Houston, TX.

Molecular probes that are tightly linked to and flank the Duchenne muscular dystrophy (DMD) locus, have been used to characterize DMD mutations and diagnose female carriers. Deletions within the Xp21 region were identified for 8 of 71 families studied. Using both DNA and CK studies, accurate (96 to 98%) carrier or noncarrier diagnoses were made for 51 of 75 females at risk in 24 families with a single affected male. DNA studies resulted in an alteration of predicted risk in 40% of the cases. Recombinant diagnostic methods are useful for carrier detection in families with one or more affected males.

Address correspondence and reprint requests to Dr. Hejtmancik, Department of Medicine, Baylor College of Medicine, Houston, TX 77030.

We gratefully acknowledge support from the MDA's Task Force on Genetics.

Accepted for publication July 14, 1986.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
P. Fortina, J. Cheng, M. A. Shoffner, S. Surrey, W. M. Hitchcock, L. J. Kricka, and P. Wilding
Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis
Clin. Chem., May 1, 1997; 43(5): 745 - 751.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J.A. Witkowski
Review Article: Dystrophin-Related Muscular Dystrophies
J Child Neurol, October 1, 1989; 4(4): 251 - 271.
[Abstract] [PDF]


Home page
ScienceHome page
J. Martin
Molecular genetics: applications to the clinical neurosciences
Science, November 6, 1987; 238(4828): 765 - 772.
[Abstract] [PDF]


Home page
ScienceHome page
C. Caskey
Disease diagnosis by recombinant DNA methods
Science, June 5, 1987; 236(4806): 1223 - 1229.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.